KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Non-Current Deferred Tax Liability (2016 - 2025)

Pfizer (PFE) has disclosed Non-Current Deferred Tax Liability for 17 consecutive years, with $12.0 billion as the latest value for Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability rose 464.0% to $12.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.0 billion through Dec 2025, up 464.0% year-over-year, with the annual reading at $12.0 billion for FY2025, 464.0% up from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2025 was $12.0 billion at Pfizer, up from $2.5 billion in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $16.2 billion in Q4 2023, with the low at $328.0 million in Q4 2021.
  • Average Non-Current Deferred Tax Liability over 5 years is $2.9 billion, with a median of $1.7 billion recorded in 2023.
  • The sharpest move saw Non-Current Deferred Tax Liability crashed 96.75% in 2021, then soared 1480.84% in 2023.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $349.0 million in 2021, then skyrocketed by 193.12% to $1.0 billion in 2022, then skyrocketed by 1480.84% to $16.2 billion in 2023, then tumbled by 86.88% to $2.1 billion in 2024, then soared by 464.0% to $12.0 billion in 2025.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods came in at $12.0 billion, $2.5 billion, and $2.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.